Stevenson VL - Search Results

1

Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.

Farrell R, Summers M, Doogan C, Mulhert N, Keenan E, Buchanan K, Lee H, Padilla H, Stevenson VL. Farrell R, et al. Among authors: stevenson vl. Mult Scler Relat Disord. 2021 May;50:102831. doi: 10.1016/j.msard.2021.102831. Epub 2021 Feb 10. Mult Scler Relat Disord. 2021. PMID: 33618123

2

A novel cause of intrathecal baclofen overdosage: lessons to be learnt.

Dalton C, Keenan E, Stevenson V. Dalton C, et al. Clin Rehabil. 2008 Feb;22(2):188-90. doi: 10.1177/0269215507081962. Clin Rehabil. 2008. PMID: 18212039

3

The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis.

Dalton CM, Keenan E, Jarrett L, Buckley L, Stevenson VL. Dalton CM, et al. Among authors: stevenson vl. Mult Scler. 2008 May;14(4):571-2. doi: 10.1177/1352458507085552. Mult Scler. 2008. PMID: 18562512

4

Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.

Sammaraiee Y, Yardley M, Keenan L, Buchanan K, Stevenson V, Farrell R. Sammaraiee Y, et al. Mult Scler Relat Disord. 2019 Jan;27:95-100. doi: 10.1016/j.msard.2018.10.009. Epub 2018 Oct 15. Mult Scler Relat Disord. 2019. PMID: 30366276

5

Reducing Intrathecal Baclofen Related Infections: Service Evaluation and Best Practice Guidelines.

Balaratnam MS, Donnelly A, Padilla H, Simeoni S, Bahadur S, Keenan L, Lee H, Farrell R, Curtis C, Brownstone RM, Murphy M, Grieve J, Shieff C, Nayar M, Pitceathly RDS, Christofi G, Stevenson VL. Balaratnam MS, et al. Among authors: stevenson vl. Neuromodulation. 2020 Oct;23(7):991-995. doi: 10.1111/ner.13071. Epub 2019 Dec 12. Neuromodulation. 2020. PMID: 31828902

6

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Hérissé-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Camp SJ, et al. Among authors: stevenson vl. Brain. 1999 Jul;122 ( Pt 7):1341-8. doi: 10.1093/brain/122.7.1341. Brain. 1999. PMID: 10388799

7

Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis.

Stevenson VL, Miller DH. Stevenson VL, et al. Mult Scler. 1999 Aug;5(4):268-72. doi: 10.1177/135245859900500413. Mult Scler. 1999. PMID: 10467387 Review.

8

Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis.

Leary SM, Silver NC, Stevenson VL, Barker GJ, Miller DH, Thompson AJ. Leary SM, et al. Among authors: stevenson vl. Mult Scler. 1999 Oct;5(5):313-6. doi: 10.1177/135245859900500502. Mult Scler. 1999. PMID: 10516773

9

Two-year follow-up study of primary and transitional progressive multiple sclerosis.

Ingle GT, Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, Dousset V, Filippi M, Montalban X, Kalkers NF, Polman CH, Rovira A, Thompson AJ. Ingle GT, et al. Among authors: stevenson vl. Mult Scler. 2002 Apr;8(2):108-14. doi: 10.1191/1352458502ms778oa. Mult Scler. 2002. PMID: 11990866

10

The management of multiple sclerosis: current and future therapies.

Stevenson VL, Thompson AJ. Stevenson VL, et al. Drugs Today (Barc). 1998 Mar;34(3):267-82. doi: 10.1358/dot.1998.34.3.485182. Drugs Today (Barc). 1998. PMID: 15094856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results